Halozyme
HALO
195 hedge funds and large institutions have $1.77B invested in Halozyme in 2018 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 31 closing their positions.
108% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $5.54M
14% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 58
1% more funds holding
Funds holding: 193 → 195 (+2)
10% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 31
1.48% less ownership
Funds ownership: 85.29% → 83.8% (-1.5%)
21% less capital invested
Capital invested by funds: $2.23B → $1.77B (-$462M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$8.61M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.25M |
| 3 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$7.12M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$6.81M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$6.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
-$40.8M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.6M |
| 3 |
Bank of New York Mellon
New York
|
-$16.5M |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$9.09M |
| 5 |
Two Sigma Investments
New York
|
-$6.85M |
HALO Hedge Fund Activity: Q4 2018 in Review
195 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2018, worth a combined $1.77B — down 21% from $2.23B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new HALO positions and 31 closed out — a net gain of 3 holders — while 66 added to existing stakes and 58 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $8.61M. The largest seller was MSD Partners, exiting entirely with an estimated $40.8M sold.
- 195 institutional investors held Halozyme (HALO) as of Q4 2018, up from 193 in Q3 2018.
- Funds reported $1.77B of Halozyme stock for Q4 2018, down 21% quarter-over-quarter.
- 34 funds opened new Halozyme positions in Q4 2018 and 31 closed out, a net change of +3 holders.
- The largest Halozyme buyer in Q4 2018 was JP Morgan Chase, an estimated $8.61M added.
- The largest Halozyme seller in Q4 2018 was MSD Partners, an estimated $40.8M sold.
Based on aggregated 13F filings for Q4 2018.